» Articles » PMID: 20461373

Inorganic Nanomaterials for Tumor Angiogenesis Imaging

Overview
Date 2010 May 13
PMID 20461373
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Tumor angiogenesis plays an important role in cancer development and metastasis. Noninvasive detection of angiogenic activities is thus of great importance in cancer diagnosis as well as evaluation of cancer therapeutic responses. Various angiogenesis-related molecular targets have been identified and used in tumor vasculature targeting and imaging. Recently, inorganic nanomaterials with various unique intrinsic physical properties have attracted growing interest in biomedical imaging applications. This article will review current progresses in the applications of inorganic nanoprobes in molecular angiogenesis imaging.

Discussion: Several types of nanomaterials with various optical properties, including semiconductor quantum dots (QDs), single-walled carbon nanotubes (SWNTs), upconversion nanoparticles (UCNPs), and surface-enhanced Raman scattering (SERS) nanoparticles, have been used as novel optical probes to image angiogenic events. Besides optical imaging, magnetic resonance imaging (MRI) of angiogenesis using magnetic nanoparticles has also been intensively investigated. Moreover, nanomaterials provide unique platforms for the integration of various imaging modalities together with therapeutic functionalities for multi-modality imaging and therapy.

Conclusion: Although the application of inorganic nanomaterials in clinical imaging and diagnosis is still facing many challenges, the unique properties and functions of these novel nanoprobes make them very promising agents in angiogenesis imaging and could bring great opportunities to this fast-growing field.

Citing Articles

CNTs mediated CD44 targeting; a paradigm shift in drug delivery for breast cancer.

Singhai N, Ramteke S Genes Dis. 2020; 7(2):205-216.

PMID: 32215290 PMC: 7083711. DOI: 10.1016/j.gendis.2019.10.009.


Nanoparticle- and Nanoporous-Membrane-Mediated Delivery of Therapeutics.

Mabrouk M, Rajendran R, Soliman I, Ashour M, Beherei H, Tohamy K Pharmaceutics. 2019; 11(6).

PMID: 31234394 PMC: 6631283. DOI: 10.3390/pharmaceutics11060294.


Anionic Long-Circulating Quantum Dots for Long-Term Intravital Vascular Imaging.

Wang H, Yang H, Xu Z, Liu X, Roberts M, Liang X Pharmaceutics. 2018; 10(4).

PMID: 30463341 PMC: 6321227. DOI: 10.3390/pharmaceutics10040244.


Nanotechnologies in Pancreatic Cancer Therapy.

Manzur A, Oluwasanmi A, Moss D, Curtis A, Hoskins C Pharmaceutics. 2017; 9(4).

PMID: 28946666 PMC: 5750645. DOI: 10.3390/pharmaceutics9040039.


Safe clinical use of carbon nanotubes as innovative biomaterials.

Saito N, Haniu H, Usui Y, Aoki K, Hara K, Takanashi S Chem Rev. 2014; 114(11):6040-79.

PMID: 24720563 PMC: 4059771. DOI: 10.1021/cr400341h.


References
1.
Ciardiello F, Caputo R, Damiano V, Caputo R, Troiani T, Vitagliano D . Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. Clin Cancer Res. 2003; 9(4):1546-56. View

2.
Sun , Murray , Weller , Folks , Moser . Monodisperse FePt nanoparticles and ferromagnetic FePt nanocrystal superlattices. Science. 2000; 287(5460):1989-92. DOI: 10.1126/science.287.5460.1989. View

3.
Gupta A, Gupta M . Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005; 26(18):3995-4021. DOI: 10.1016/j.biomaterials.2004.10.012. View

4.
Michalet X, Pinaud F, Bentolila L, Tsay J, Doose S, Li J . Quantum dots for live cells, in vivo imaging, and diagnostics. Science. 2005; 307(5709):538-44. PMC: 1201471. DOI: 10.1126/science.1104274. View

5.
Ruoslahti E . RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol. 1996; 12:697-715. DOI: 10.1146/annurev.cellbio.12.1.697. View